- Home
- RAND vs CRVO Comparison
RAND vs CRVO Comparison
Compare RAND & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAND
- CRVO
- Stock Information
- Founded
- RAND 1969
- CRVO 2001
- Country
- RAND United States
- CRVO United States
- Employees
- RAND N/A
- CRVO N/A
- Industry
- RAND Finance: Consumer Services
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- RAND Finance
- CRVO Health Care
- Exchange
- RAND Nasdaq
- CRVO Nasdaq
- Market Cap
- RAND 57.6M
- CRVO 67.4M
- IPO Year
- RAND N/A
- CRVO N/A
- Fundamental
- Price
- RAND $16.48
- CRVO $6.05
- Analyst Decision
- RAND
- CRVO Strong Buy
- Analyst Count
- RAND 0
- CRVO 8
- Target Price
- RAND N/A
- CRVO $25.57
- AVG Volume (30 Days)
- RAND 5.7K
- CRVO 133.6K
- Earning Date
- RAND 08-05-2025
- CRVO 08-08-2025
- Dividend Yield
- RAND 10.39%
- CRVO N/A
- EPS Growth
- RAND 39.77
- CRVO N/A
- EPS
- RAND 3.12
- CRVO N/A
- Revenue
- RAND $8,499,970.00
- CRVO $9,308,215.00
- Revenue This Year
- RAND N/A
- CRVO N/A
- Revenue Next Year
- RAND N/A
- CRVO N/A
- P/E Ratio
- RAND $5.17
- CRVO N/A
- Revenue Growth
- RAND 12.52
- CRVO 15.14
- 52 Week Low
- RAND $14.01
- CRVO $1.80
- 52 Week High
- RAND $31.89
- CRVO $20.63
- Technical
- Relative Strength Index (RSI)
- RAND 54.96
- CRVO 33.86
- Support Level
- RAND $15.00
- CRVO $6.31
- Resistance Level
- RAND $15.75
- CRVO $7.20
- Average True Range (ATR)
- RAND 0.34
- CRVO 0.53
- MACD
- RAND 0.20
- CRVO -0.07
- Stochastic Oscillator
- RAND 100.00
- CRVO 0.00
About RAND Rand Capital Corporation
Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. The company's investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.